Mark Milad obtained a BS in Pharmacy from Duquesne University and a Pharm D from Wayne State University before completing a Clinical Pharmacology Fellowship in Pharmacokinetics, Pharmacodynamics and Immunology at the State University of New York at Buffalo.

After gaining extensive experience at Parke-Davis, Pfizer and Metabasis Therapeautics, Mark started privately consulting for the pharmaceutical industry where he utilizes his vast experience of 25+ years applying clinical pharmacology skills and insights to drug development.

He has preclinical development experience, evaluates compounds for in-licensing, and has held leadership roles on development teams. His work focuses on optimal design of the drug development program by applying PK/PD principles, analysis and modeling & simulation.